Definiens Expands Functionality of Its Leading#Solution for Quantitative Digital Pathology with#Gene Probe Analysis

About Definiens

Definiens is the leading provider of image analysis and data mining solutions for quantitative digital pathology in the life sciences, diagnostic biomarkers and healthcare industries. Definiens software provides detailed readouts from whole tissue slides, cell-based assays and full body scans and allows correlating this information with data derived from other sources. By automating analysis workflows, Definiens helps pharmaceutical and biotechnology companies, research institutions, clinical service organizations and pathologists to generate new knowledge and supports better decisions in research, diagnostics and therapy. Definiens’ vision is to open new fields of research, to contribute to development of personalized medicine and to significantly improve the quality of patients’ lives.

Definiens is headquartered in Munich, Germany, and has offices throughout the United States. Further information is available at www.definiens.com.

Press Contacts

Definiens, Inc.
Dr. Florian Leiss
Manager Marketing Communications
fleiss@definiens.com
0049.89.2311.8024

Ricochet PR
Steven Pludwin
spludwin@ricochetpr.com
001.212.679.3300 ext 136